表观基因组分析识别纤维化间质性肺病中污染敏感位点
该回顾性双队列研究将卫星衍生PM2.5及成分暴露与纤维化间质性肺病患者居住地匹配,采用稳健线性回归评估全表观基因组血液DNA甲基化。匹兹堡队列(n=306)5年中位PM2.5为12.1 μg/m3,不列颠哥伦比亚队列(n=170)为5.1 μg/m3。高暴露与CRTAP基因cg25354716低甲基化相关,该位点甲基化升高10%与死亡或肺移植风险比0.81相关(95%CI 0.69-0.96;P=0.01)。
要点
- PM2.5暴露与fILD患者血液DNA甲基化改变相关。
- cg25354716甲基化升高10%与死亡或肺移植风险降低相关(HR=0.81)。
- CRTAP蛋白在fILD肺组织中较供体对照更丰富(P<0.001)。
核心结论
- PM2.5与纤维化间质性肺病患者的血液DNA甲基化改变相关。
- 本研究识别出新的污染敏感靶点,具有治疗调控潜力。
研究设计与样本
- 回顾性双队列研究,应用卫星衍生PM2.5及成分暴露与患者居住地匹配。
- 匹兹堡队列n=306,不列颠哥伦比亚队列n=170。
- 采用稳健线性回归评估队列特异性全表观基因组血液DNA甲基化(Illumina MethylationEPIC BeadChip)。
- 采用Cox和线性回归评估CpG位点与无移植生存及肺功能的关联。
- 采用Wilcoxon检验评估fILD与对照肺组织中CRTAP水平。
主要发现
- 匹兹堡队列5年中位PM2.5暴露为12.1 μg/m3,不列颠哥伦比亚队列为5.1 μg/m3。
- 匹兹堡队列较高暴露与cg25354716(注释至CRTAP)较低甲基化相关。
- 不列颠哥伦比亚队列较高暴露与cg01019301(注释至TLN2)较高甲基化相关。
- cg25354716甲基化增加10%与死亡或肺移植风险比0.81相关(95%CI 0.69-0.96;P=0.01)。
- cg01019301甲基化增加10%与死亡或肺移植风险比1.36相关(95%CI 1.07-1.74;P=0.01)。
关键数值与推荐
- 匹兹堡队列5年中位PM2.5暴露12.1 μg/m3,不列颠哥伦比亚队列5.1 μg/m3。
- cg25354716甲基化增加10%对应HR=0.81(95%CI 0.69-0.96;P=0.01)。
- cg01019301甲基化增加10%对应HR=1.36(95%CI 1.07-1.74;P=0.01)。
- CRTAP蛋白在fILD肺组织较供体对照更丰富(P<0.001)。
临床怎么用
- PM2.5暴露评估可能有助于识别fILD中表观遗传改变的高危患者。
- CRTAP和TLN2相关甲基化位点可能作为未来治疗调控的候选靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Particulate matter ⩽2.5 μm (PM2.5) adversely impacts patients with fibrotic interstitial lung disease (fILD). Objectives: We sought to determine whether PM2.5-associated epigenetic alterations contribute to the environmental pathogenesis of fILD. Methods: A retrospective two-cohort study applied satellite-derived PM2.5 and constituent exposure matching to the residential location of patients with fILD. Robust linear regressions were used to evaluate cohort-specific, epigenome-wide differential blood DNA methylation with increasing pollutant exposures (Illumina MethylationEPIC BeadChip). Cox and linear regressions were used to evaluate associations of cytosine-phosphate-guanine (CpG) loci with transplant-free survival and lung function. A Wilcoxon test was used to evaluate cartilage-associated protein (CRTAP) levels in fILD and control lungs. Measurements and Main Results: The University of Pittsburgh cohort (n = 306) had 5-year median PM2.5 exposures of 12.1 μg/m3 compared with 5.1 μg/m3 in the University of British Columbia cohort (n = 170). Higher pollutant exposures in the University of Pittsburgh cohort were associated with lower methylation at cg25354716, annotated to CRTAP, a critical extracellular matrix remodeling enzyme. Higher exposures in the University of British Columbia cohort were associated with higher methylation at cg01019301, annotated to TLN2 (talin-2), a cytoskeletal protein involved in fibroblast migration. A 10% increase in cg25354716 methylation was associated with a hazard ratio of 0.81 for death or lung transplantation in the meta-analyzed cohorts (95% confidence interval = 0.69-0.96; P = 0.01), whereas the same change in cg01019301 was associated with a hazard ratio of 1.36 (95% confidence interval = 1.07-1.74; P = 0.01). CRTAP protein was more abundant in lungs from patients with fILD compared with those from donor controls (P < 0.001). Conclusions: PM2.5 is associated with altered blood DNA methylation in fILD. This work identifies novel pollution-sensitive targets that hold potential for therapeutic modulation in fILD.
引用
- Goobie GC, Assadinia N, Yang CX, et al. Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung Disease. Am J Respir Crit Care Med. 2025. PMID: 40540633. doi:10.1164/rccm.202407-1504OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。